Literature DB >> 2288721

Chronic major aphthous stomatitis: oral treatment with low-dose alpha-interferon.

V A Hutchinson1, W L Mok, J L Angenend, J M Cummins, A B Richards.   

Abstract

Two patients with chronic major aphthous stomatitis of at least 3 years duration were treated with single daily oral doses (1,200 IU) of interferon alfa-2 alpha (HuIFN alpha). Both patients responded with complete remission of aphthae within 6 weeks. One patient had no recurrence of the disease during a 6-month observation period. The second patient had a recurrent aphtha approximately 4 weeks after the initial lesion resolved; however, the recurrent lesion was less severe than the patient had historically experienced. Retreatment of the recurrent lesion with HuIFN alpha resulted in complete remission within 1 week, and there were no further recurrences during the 6-month observational period.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2288721

Source DB:  PubMed          Journal:  Mol Biother        ISSN: 0952-8172


  3 in total

Review 1.  Absorption of cytokines via oropharyngeal-associated lymphoid tissues. Does an unorthodox route improve the therapeutic index of interferon?

Authors:  V Bocci
Journal:  Clin Pharmacokinet       Date:  1991-12       Impact factor: 6.447

2.  Oral administration of interferon-α2b-transformed Bifidobacterium longum protects BALB/c mice against coxsackievirus B3-induced myocarditis.

Authors:  Zhijian Yu; Zhen Huang; Chongwen Shao; Yuanjian Huang; Fan Zhang; Jin Yang; Lili Deng; Zhongming Zeng; Qiwen Deng; Weiseng Zeng
Journal:  Virol J       Date:  2011-12-08       Impact factor: 4.099

Review 3.  Oromucosal Administration of Interferon to Humans.

Authors:  Manfred W Beilharz; Martin J Cummins; Alayne L Bennett; Joseph M Cummins
Journal:  Pharmaceuticals (Basel)       Date:  2010-01-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.